Tropomyosin receptor kinase B (TrkB) is activated by the brain-derived neurotrophic factor (BDNF) as its main endogenous ligand, and together they constitute a critical signaling system involved in regulating brain plasticity and restoration. Disruption of this system has been implicated in a number of psychiatric disorders such as depression, anxiety and schizophrenia, and thus TrkB has emerged as an important therapeutic target. However, previous efforts to identify small molecule BDNF mimics and TrkB modulators have not been successful using the established discovery platforms (e.g. high-throughput screening of drug- like compounds and computational design and screening). In this exploratory R21 application, we propose to develop a novel ligand discovery approach, based on the massive combinatorial power of peptide phage display and specific selection conditions, to identify small peptides that modulate the active form of the TrkB receptor. We will develop and validate this new approach, perform phage library screening, identify hit peptide sequences, and conduct preliminary examination of the functional parameters of the top peptides (potency, efficacy, and mode of TrkB modulation in the presence and absence of BDNF). If successful, this project will chart a course for the development of the first robust, small molecule TrkB modulators, and suggest the applicability of this new discovery approach to other challenging molecular targets.

Public Health Relevance

Successful treatment of complex brain disorders such as depression and anxiety may require restoration of neuronal and synaptic connectivity and function. Several receptors, including the tyrosine receptor kinase TrkB, have been shown to promote such restorative processes when properly stimulated. In this exploratory project, we will seek to demonstrate that screening peptide libraries displayed on bacteriophage particles, a powerful approach used successfully in cancer research, can be harnessed to identify peptides capable of modulating the function of complex receptor systems like TrkB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21MH116275-02
Application #
9655375
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Michelotti, Enrique
Project Start
2018-03-01
Project End
2021-02-28
Budget Start
2019-03-01
Budget End
2021-02-28
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Chemistry
Type
Graduate Schools
DUNS #
049179401
City
New York
State
NY
Country
United States
Zip Code
10027